Stock to buy: Fortis Healthcare share price outlook is unlikely to be impacted by the probe directed by the Delhi HC last week, according to PL Capital report. The hospital chain stock is poised for a double digit growth in the long-term.
Fortis Healthcare Share Price Recommendation: The hospital chain stock is poised for nearly 16% upside on long-term. (AI generated image for representational purposes only)
Stock to buy: Shares of Fortis Healthcare Limited continued to rise for the second consecutive day on Tuesday, September 8, but Prabhudas Lilladher remains bullish on the healthcare stock. Despite a 66% rally over two years, the brokerage sees nearly 16% upside.
Last week, the Delhi HC directed the appointment of an auditor to probe alleged asset dissipation by the company's former promoters. The forensic audit is limited to historical shareholding changes and will “have no impact on FORH’s capex, brownfield expansion or M&A plans,” stated PL Capital in its latest report.
Fortis Healthcare share price prediction
Fortis Healthcare has delivered strong, volume-led growth in the hospital segment over the past 15 months, and the company has maintained occupancy at an elevated 68-69% despite a 17% increase in operating beds over the past year.
There are signs of recovery in the diagnostics segment with an improving test mix supporting better realisations. The Gurgaon-headquartered hospital chain giant.
The hospital reported a margin improvement by 530 bps over FY23-26 to 22.2%. Improving case mix, cost rationalisation initiatives, new brownfield bed additions are likely to boost scope for improvement, according to PL Capital.
“We expect FORH to clock 20% EBITDA CAGR ex ESOP over FY26-28E. At CMP, the stock is trading at 24.4x EV/EBITDA on FY28E, adjusted for Agilus stake and ESOP,” stated the brokerage in its report.
Fortis Healthcare share price target
PL Capital maintained a ‘Buy’ rating for the stock with a target price of ₹1,050 per share. The stock maintained “‘BUY’ rating with revised TP of INR 1,050/ share; valuing at 28x EV/EBITDA (30x earlier) for the hospital segment on FY28E.”
View full Image
PL Capital has given a Buy rating for Fortis Healthcare with ₹1050 target price
Fortis Healthcare share price trend
The stock was trading 0.21% higher at ₹910.21 per share on BSE with a market capitalisation of ₹68,716.29 crore at 1:40 pm on Tuesday. The stock had touched an intraday high of ₹912.70 per share and an intraday low of ₹903.50 per share.
The healthcare stock touched its 52-week high of ₹1,105 per share on October 13, 2025. The stock dipped to its 52-week low of ₹767.30 per share on April 2, 2026. With a return on equity (ROE) of 2.49%, the scrip has delivered close to 66% return in two years. But it has declined around 1.3% in two weeks, 5.26% in two weeks, and 7.9% in three months.
Fortis Healthcare shareholding pattern
The integrated healthcare delivery service provider is owned by a cluster of promoters, institutional investors, domestic institutions, etc. As per PL Capital report, promoters hold 31.17% stake in Fortis Healthcare. Whereas, FIIs and mutual funds own 25.2% and 25.81% stake in the company. Public & others own around 11.4% stake.
Disclaimer: This story is for educational and informational purposes only. The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified financial experts before making any investment decisions.
